BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  DJO Global Announces Financial Results for Third Quarter 2017

  Net sales grew 1.3% to $290.9 million, or 0.3% at constant currency rates.

  November 14, 2017

   · 

  21 min read
• Drug Development

  Cytokinetics Announces Additional Results From COSMIC-HF at the American Heart Association Scientific Sessions 2017

  The data was presented by John Teerlink, M.D. in an Abstract Rapid Fire Oral presentation at the American Heart Association Scientific Sessions 2017 in Anaheim, Calif.

  November 14, 2017

   · 

  9 min read
• New Study Using Artificial Intelligence Shows Prevencio’s Simple Blood Test Accurately Detects Presence of Peripheral Artery Disease

  Novel multi-protein test data with 98% accuracy presented at American Heart Association 2017 Scientific Sessions.

  November 14, 2017

   · 

  4 min read
• Drug Development

  Gemphire Presents Data at AHA Scientific Sessions Showing that Gemcabene Significantly Reduces Atherogenic Remnant Lipoprotein and LDL-C as Add-on to Statins in a Cardiometabolic Population and Reports Third Quarter 2017 Financial Results

  The study results were featured in poster presentations Sunday November 12th and today at the American Heart Association® (AHA) in Anaheim, California.

  November 14, 2017

   · 

  12 min read
• Business

  Hanger Announces Changes to Board of Directors

  Hanger today announced its Board of Directors has elected Thomas C. Freyman and John T. Fox as directors, effective November 14, 2017.

  November 14, 2017

   · 

  6 min read
• Business

  Windtree Therapeutics Reports Third Quarter 2017 Financial Results

  For the quarter ended September 30, 2017, the Company reported an operating loss of $4.8M, compared to $7.7M for the third quarter of 2016.

  November 14, 2017

   · 

  17 min read
• Business

  Year-to-Date Gross Sales for Mytesi, the FDA-Approved Human Prescription Drug Product of Jaguar Health’s Wholly-Owned Subsidiary, Napo Pharmaceuticals, Total $2.8M

  The average monthly Mytesi sales from August through October of this year increased over 50% relative to average monthly Mytesi® sales that took place from January through July of 2017.

  November 14, 2017

   · 

  8 min read
• Business

  Biohaven Pharma Reports Third Quarter 2017 Financial And Business Results

  Biohaven Pharma today reported financial results for the quarter ended September 30, 2017, and provided a review of recent accomplishments and anticipated upcoming milestones.

  November 14, 2017

   · 

  12 min read
• Learn “Lean Lab” Terminology With the New Lean Laboratory Glossary from METTLER TOLEDO

  Lean manufacturing and management principles are finding application in R&D and quality control labs around the world as companies seek to improve overall efficiency and keep up with ever-changing markets.

  November 14, 2017

   · 

  2 min read
• Alpha Genesis Expands in to European Research Market

  The company has embarked on a further expansion program to more fully leverage its primate expertise, research design and integration skills to deliver first-to-market innovations with European clients.

  November 14, 2017

   · 

  1 min read